Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking
Open Access
- 1 July 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (7) , 1222-1230
- https://doi.org/10.1038/sj.gt.3300942
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cis-Active Elements of Friend Spleen Focus-Forming Virus: From Disease Induction to Disease PreventionActa Haematologica, 1998
- Impact of a new generation of gene transfer markers on gene therapyGene Therapy, 1998
- Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphomaGene Therapy, 1998
- Dominant Selection of Hematopoietic Progenitor Cells with Retroviral MDR1 Co-Expression VectorsHuman Gene Therapy, 1998
- Selective Immunoaffinity-Based Enrichment of CD34+Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) GeneHuman Gene Therapy, 1997
- Cell-Surface Marking of CD34+-Restricted Phenotypes of Human Hematopoietic Progenitor Cells by Retrovirus-Mediated Gene TransferHuman Gene Therapy, 1997
- Sustained High-Level Reconstitution of the Hematopoietic System by Preselected Hematopoietic Cells Expressing a Transduced Cell-Surface AntigenHuman Gene Therapy, 1997
- Post-Transplant Methotrexate Administration Leads to Improved Curability of Mice Bearing a Mammary Tumor Transplanted with Marrow Transduced with a Mutant Human Dihydrofolate Reductase cDNAHuman Gene Therapy, 1997
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992